This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bergenbio Asa. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Crina Tiron: Innovator in Cancer Research
Introduction
Crina Tiron is a prominent inventor based in Bergen, Norway. She has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer through innovative methods.
Latest Patents
Crina Tiron holds a patent titled "Methods of detecting Akt3 and administering Ax1 inhibitor." This patent discloses the use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject. It also details the use of Akt3 inhibitors to treat cancer. Various methods for detecting the occurrence of EMT in a subject by measuring Akt3 expression and/or activity are also included in her patent. She has 1 patent to her name.
Career Highlights
Crina Tiron is associated with Bergenbio ASA, a company that focuses on developing innovative cancer therapies. Her work has been instrumental in advancing the understanding of cancer biomarkers and treatment options.
Collaborations
Crina collaborates with Jim Lorens, who is also involved in cancer research. Their partnership has contributed to the development of new methodologies in the field.
Conclusion
Crina Tiron is a dedicated inventor whose work in cancer research is paving the way for new diagnostic and therapeutic approaches. Her innovative methods and collaborations are making a significant impact in the fight against cancer.